Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(24)00190-5
PubMed Identifier: 39542002
Publication URI: http://europepmc.org/abstract/MED/39542002
Type: Journal Article/Review
Volume: 6
Parent Publication: The Lancet. Rheumatology
Issue: 12
ISSN: 2665-9913